EUVIMEDEUVIMED entdecken
Crossref

Bay-117082 treats sepsis by inhibiting neutrophil extracellular traps (NETs) formation through down-regulating NLRP3/N-GSDMD

Shujing Zou, Xinai Han, Shugeng Luo, Quanguang Tan, Huiying Huang, Zhoulanlan Yao, Wenjing Hou, Hongyu Jie, Jinghong Wang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Shujing Zou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Extracellular Traps, Sepsis, NLR Family, Pyrin Domain-Containing 3 Protein, Sulfones. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the inflammatory storm of sepsis, a significant quantity of neutrophil extracellular traps (NETs) are generated, which act as a double-edged sword and not only impede the invasion of foreign microorganisms but also exacerbate organ damage. This study provides evidence that NETs can cause damage to alveolar epithelial cells in vitro. The sepsis model developed in this study showed a significant increase in NETs in the bronchoalveolar lavage fluid (BALF). The development of NETs has been shown to increase the lung inflammatory response and aggravate injury to alveolar epithelial cells. Bay-117082, a well-known NF-κB suppressor, is used to modulate inflammation. This analysis revealed that Bay-117082 efficiently reduced total protein concentration, myeloperoxidase activity, and inflammatory cytokines in BALF. Moreover, Bay-117082 inhibited the formation of NETs, which in turn prevented the activation of the pore-forming protein gasdermin D (GSDMD). In summary, these results indicated that excessive NET production during sepsis exacerbated the onset and progression of acute lung injury (ALI). Therefore, Bay-117082 could serve as a novel therapeutic approach for ameliorating sepsis-associated ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular TrapsSepsisNLR Family, Pyrin Domain-Containing 3 ProteinSulfonesNitrilesIntracellular Signaling Peptides and ProteinsPhosphate-Binding ProteinsAnimalsMiceAcute Lung InjuryMaleMice, Inbred C57BLHumansNeutrophilsDown-RegulationCytokinesBronchoalveolar Lavage FluidDisease Models, AnimalGasdermins

Stichwörter der Autor:innen

Acute lung injuryInflammationNeutrophil extracellular trapsNeutrophilsSepsis

Substanzen

NLR Family, Pyrin Domain-Containing 3 Protein3-(4-methylphenylsulfonyl)-2-propenenitrileSulfonesNitrilesIntracellular Signaling Peptides and ProteinsPhosphate-Binding ProteinsGsdmd protein, mouseNlrp3 protein, mouseCytokinesGasdermins

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  • Department of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  • Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China. Electronic address: 372054199@qq.com.

Zitieren

APA

Zou, S., Han, X., Luo, S., Tan, Q., Huang, H., Yao, Z., Hou, W., Jie, H., & Wang, J. (2024). Bay-117082 treats sepsis by inhibiting neutrophil extracellular traps (NETs) formation through down-regulating NLRP3/N-GSDMD. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112805

Vancouver

Zou S, Han X, Luo S, Tan Q, Huang H, Yao Z, et al. Bay-117082 treats sepsis by inhibiting neutrophil extracellular traps (NETs) formation through down-regulating NLRP3/N-GSDMD. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112805

BibTeX
@article{Zou2024,
  author = {Zou, Shujing and Han, Xinai and Luo, Shugeng and Tan, Quanguang and Huang, Huiying and Yao, Zhoulanlan and Hou, Wenjing and Jie, Hongyu and Wang, Jinghong},
  title = {Bay-117082 treats sepsis by inhibiting neutrophil extracellular traps (NETs) formation through down-regulating NLRP3/N-GSDMD},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112805}
}
Kostenlos starten →